Verastem, Inc. (VSTM)
NASDAQ: VSTM · Real-Time Price · USD
5.72
0.00 (0.00%)
At close: Feb 27, 2026, 4:00 PM EST
5.80
+0.08 (1.40%)
After-hours: Feb 27, 2026, 7:51 PM EST
Verastem Market Cap
Verastem has a market cap or net worth of $441.48 million as of February 27, 2026. Its market cap has increased by 63.15% in one year.
Market Cap
441.48M
Enterprise Value
393.25M
1-Year Change
63.15%
Ranking
Category
Stock Price
$5.72
Market Cap Chart
Since January 27, 2012, Verastem's market cap has increased from $213.30M to $441.48M, an increase of 106.98%. That is a compound annual growth rate of 5.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 382.00M | -25.90% |
| Dec 31, 2025 | 515.50M | 124.03% |
| Dec 31, 2024 | 230.10M | 11.86% |
| Dec 29, 2023 | 205.70M | 143.14% |
| Dec 30, 2022 | 84.60M | -77.35% |
| Dec 31, 2021 | 373.50M | 3.29% |
| Dec 31, 2020 | 361.60M | 263.05% |
| Dec 31, 2019 | 99.60M | -59.81% |
| Dec 31, 2018 | 247.80M | 99.36% |
| Dec 29, 2017 | 124.30M | 200.24% |
| Dec 30, 2016 | 41.40M | -39.74% |
| Dec 31, 2015 | 68.70M | -70.98% |
| Dec 31, 2014 | 236.70M | -19.05% |
| Dec 31, 2013 | 292.40M | 56.53% |
| Dec 31, 2012 | 186.80M | -12.42% |
View and export this data all the way back to 2012.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Prothena Corporation | 468.32M |
| Lineage Cell Therapeutics | 466.48M |
| REGENXBIO | 457.63M |
| Autolus Therapeutics | 449.78M |
| Keros Therapeutics | 439.32M |
| Entrada Therapeutics | 437.87M |
| Immix Biopharma | 434.14M |
| DiaMedica Therapeutics | 430.23M |